Rostafuroxin
- Generic Name
- Rostafuroxin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H34O4
- CAS Number
- 156722-18-8
- Unique Ingredient Identifier
- P848LCX62B
- Background
Rostafuroxin has been used in trials studying the treatment of Essential Hypertension.
- Associated Conditions
- -
- Associated Therapies
- -
Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan
- First Posted Date
- 2017-07-14
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Windtree Therapeutics
- Target Recruit Count
- 240
- Registration Number
- NCT03217825
- Locations
- ๐จ๐ณ
Cvie Therapeutics Limited, Taipei, Taiwan
Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations
- First Posted Date
- 2011-03-22
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- RostaQuo S.p.A.
- Target Recruit Count
- 240
- Registration Number
- NCT01320397
- Locations
- ๐ฎ๐ช
Portiuncula Hospital, Ballinasloe, Galway, Ireland
๐ฎ๐นOspedale "Santa Maria", Borgo Val di Taro, Parma, Italy
๐ฎ๐ชJames Connolly memorial Hospital, Dublin, Ireland
Efficacy of Rostafuroxin in the Treatment of Essential Hypertension
- First Posted Date
- 2006-12-22
- Last Posted Date
- 2011-06-17
- Lead Sponsor
- sigma-tau i.f.r. S.p.A.
- Target Recruit Count
- 438
- Registration Number
- NCT00415038
- Locations
- ๐ง๐ช
Catholic University of Leuven - Laboratory of Hypertension, Dept. of Molecular and Cardiov. Research - Campus Gasthuisberg, Leuven, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2024. All Rights Reserved by MedPath